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Abstract. Back-Referral Program (PRB) is one way to improve the quality of the health services for BPJS participants in 
conducting quality control and cost control. The unavailability of pharmacies and drugs for PRB causes the PRB program 
not to run optimally, thus increasing the catastrophic disease sufferers and absorbing big claims in JKN. This study is 
qualitative research with a descriptive approach using the method of in-depth interviews and document review. The 
research informants' criteria were: the elements of the leadership and policy management officers in the DKI Jakarta 
Provincial Health Office, Central Jakarta Health Office, Central Jakarta BPJS Health Center, Central Jakarta District 
Health Center, and Central Jakarta PRB Pharmacy. The results showed that the implementation performance was not 
optimal, which was influenced by policy standards and objectives, resources, communication between organizations, the 
implementers' attitude, the implementing organization's characteristics, and the economic, social, and politics. 
Coordination, commitment, and evaluation of activities from the Ministry of Health, BPJS Health, Government Service 
Goods Procurement Policy Institute, and DKI Jakarta Provincial Health Office are needed in terms of the availability of 
this PRB drug 
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Abstrak. Program Rujuk Balik (PRB) merupakan salah satu cara meningkatkan kualitas pelayanan kesehatan bagi 
peserta BPJS dalam melakukan kendali mutu dan kendali biaya. Ketersediaan Apotek PRB dan ketidaktersediaan obat 
di Apotek PRB menyebabkan PRB bagi pasien yang membutuhkan obat berjalan tidak maksimal, dapat meningkatkan 
penderita penyakit katastropik dan menyerap klaim besar dalam JKN . Penelitian ini adalah penelitian kualitatif dengan 
pendekatan deskriptif menggunakan metode wawancara mendalam dan telaah dokumen. Kriteria informan penelitian 
adalah unsur pimpinan dan petugas pengelola kebijakan pada Dinas Kesehatan Provinsi DKI Jakarta, Suku Dinas 
Kesehatan Jakarta Pusat, BPJS Kesehatan Cabang Jakarta Pusat, Subdistrict primary healthcare Se-Jakarta Pusat dan 
Apotek PRB Se-Jakarta Pusat. Hasil penelitian menunjukkan bahwa kinerja implementasi belum optimal yang 
dipengaruhi oleh standar dan sasaran kebijakan, sumber daya, komunikasi antar organisasi, sikap para pelaksana, 
karakteristik organisasi pelaksana dan lingkungan ekonomi, sosial serta politik. Diperlukan koordinasi, komitmen dan 
evaluasi kegiatan dari Kementerian Kesehatan, BPJS Kesehatan, Lembaga Kebijakan Pengadaan Barang/Jasa 
Pemerintah (LKPP) serta Dinas Kesehatan Provinsi DKI Jakarta dalam hal ketersediaan obat PRB ini.  
 




Referral Program Services (PRB) are health services 
provided to patients with chronic diseases with stable 
conditions and still need long-term treatment or 
nursing care at the First Level Health Care Services 
(FKTP) on recommendation/referral from the treating 
Specialist/Sub Specialist. The scope of PRB includes   
 
Diabetes Mellitus, Hypertension, Heart, Asthma, 
Chronic Obstructive Pulmonary Disease (COPD), 
Epilepsy, Schizophrenia, Stroke, and Systemic Lupus 
Erythematosus (SLE) .
1 
Drug unavailability at PRB Pharmacy is one of the 
problems of maintaining quality and cost control. 
Research at BPJS Kesehatan Central Jakarta in June - 
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Six variables that influence public policy are policy 
standards and objectives, resources, characteristics of 
the implementing organization, communication 
between related organizations and implementation 
activities, dispositions or attitudes of the implementers, 





This research is qualitative research with a descriptive 
approach using in-depth interviews and document 
review. The research location is at the DKI Jakarta 
Health Office, City Health Office, BPJS office, eight 
district primary health care, and eight PRB Pharmacies 
in Central Jakarta. This research has received a 
recommendation letter from the Ethics Commission for 
research and community health service, Faculty of 
Public Health, University of Indonesia number: 411 / 
UN2.F10 / PPM.00.02 / 2019 dated 11 June 2019.  
The research informants were the Head of the Food and 
Beverage Pharmacy Section of the DKI Jakarta Health 
Office (1 person), the Heads of the District Primary 
Healthcare (7 people), the chief of Pharmacy at the 
Health Office (1 person), head pharmacist for the 
District Primary Healthcare (8 people), the Pharmacist 
in charge of the PRB Pharmacy (9 people), and the head 
branch of BPJS Primary Benefit Insurance (1 person) in 
the Central Jakarta area. Informed consent was given to 
informants before the researchers took primary and 
secondary data.  
The data analysis procedure steps: informant 
descriptions, compiling transcript notes, data 
organization, data categorization/coding, summarizing 
data into matrices, identifying variables and 
relationships between variables, and drawing 
conclusions. The data triangulation approach uses 
technical triangulation, data retrieval utilizing in-depth 
interviews, observation, document review, and source 
triangulation by collecting data from several informants 
and comparing data obtained from one informant with 
other informants. 
 
RESULT AND DISCUSSION 
Kinerja Implementasi Kebijakan terkait Penyediaan 
Obat PRB 
In the 3rd quarter of 2019, pharmacies that collaborate 
with BPJS Kesehatan in providing PRB drugs are Kimia 
Farma 1 Garuda Pharmacy, Kimia Farma 2 Senen 
Pharmacy, Kimia Farma 5 Cikini Pharmacy, Kimia 
Farma 6 Pejompongan Pharmacy, 198 Kimia Farma 
Pharmacy Percetakan Negara, a Pharmacy Kimia Farma 
298 Bendungan Hilir, Kimia Farma Pharmacy Menteng 
Huis, Pharmacy Sana Farma Percetakan Negara, Sawah 
August 2014 showed that PRB drug unavailability was 
found from the unserved drug demand, which was 
43.2% participants in June, 15.2% participants in July, 
and 9.7% participants in August 2014.2 Therefore, 
many patients buy their own drugs or do not even 
consume drugs that trigger catastrophic diseases. 
Catastrophic health spending can lead to 
impoverishment. The indirect economic impact of 
chronic disease is reduced income due to lost 
productivity due to illness or death, reduced 
opportunities for savings, and loss of employment or 
education opportunities. Groups of catastrophic 
diseases such as kidney failure, cardiovascular, cancer, 
thalassemia, and hemophilia create the most significant 
spending from the National Health Insurance (JKN), 




On 5 September 2019 in Jakarta, Director of BPJS 
Health Service Security, Maya A Rusadi, stated that in 
the BPJS records that catastrophic diseases cost Rp. 
11.07 trillion in 2014, Rp. 14.88 trillion in 2015, Rp. 
16.94 trillion in 2016, IDR 18.44 trillion in 2017, IDR 
20.42 trillion in 2018, and approximately IDR 10 
trillion in June 2019. This condition also happened 
with an increasing number of participants. 
Central Jakarta BPJS data shows 8 PRB pharmacies in 
Central Jakarta out of 293 Pharmacies at the beginning 
of 2019. The unavailability of PRB Pharmacies drugs 
at the PRB Pharmacy caused the PRB program not to 
be optimal. Even though sub-district primary 
healthcare has an E-catalog system to optimize drug 
availability, many still cannot run PRB optimally.  
The purpose of this study was to determine the 
performance of policy implementation related to the 
availability of PRB drugs in the sub-district health 
center pharmacy room and PRB pharmacy in Central 
Jakarta for the first, second, and third quarters of 2019 
based on the Republic of Indonesia Minister of Health 
Regulation Number 99 of 2015 concerning health 
services on JKN article 25. To ensure PRB drugs' 
availability, BPJS Kesehatan must collaborate with 
pharmacies or pharmacy installations in FKTPs that 
are easily accessible to JKN participants.
5
  
According to Dunn (2004), there are three policy 
elements: political actors, policy environment, and 
public policies.6 Policy implementation is the fourth 
stage after the agenda-setting, policy formulation, and 
policy adoption stages, followed by the policy 
evaluation stage in the policy formulation or 
development cycle. 7 To determine the performance of 
policy implementation in this study, we use a policy 
model theory according to Van Meter and Van Horn. 
Van Meter and Van Horn's policy model states that 
policy implementation runs linearly from public 
policy, implementor, and public policy performance. 
117 
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Besar District Primary Healthcare and Kemayoran 
District Primary Healthcare. 
The Head of the DKI Jakarta Provincial Health Office 
did the first socialization of PRB drugs for primary 
healthcare at the Regional Health Work Meeting in 
April 2019. DRR drugs, provided for district primary 
healthcare as a Pilot Project, are for hypertension 
diagnosis without any complications. The PRB 
Pharmacist serves 8 Other diagnoses at the primary 
healthcare pharmacy room. Another primary healthcare 
provides a pharmacy room for the PRB Pharmacist, 
while the remaining five Primary healthcare are waiting 
for instructions and planning preparations.   
Obstacles faced in implementing policies were:  
1. The procurement of PRB DRR drugs was done 
suddenly in the middle of the year budget. Primary 
healthcare cannot do planning for drugs that are not 
FKTP drugs or outside the Fornas PRB drugs. 
There is still no derivative of the legal aspect. There 
is no data on the drug types, the number of PRB 
drugs, and the number of PRB patients that should 
be served at the primary healthcare. 
2. The PRB pharmacy.  The PRB pharmacy cannot 
buy drugs through e-purchasing or combining PRB 
drugs with other drugs for the pharmacy, resulting 
in drug unavailability. The information provided by 
the hospital for patients is lacking. Primary 
healthcare does not directly enter the visit number; 
thus, it cannot be read in online pharmacies. 
Patients sometimes no longer take PRB drugs for 
various reasons, such as worsening conditions, 
moving to other healthcare facilities. Officers are 
less accustomed to open online applications. 
3. The triangulation results are: the availability of 
pharmacies and PRB drugs, the unavailability of e-
purchasing accounts at PRB pharmacies, 
replacement of regular drugs with e-catalog prices, 
availability of facilities and infrastructure, PRB 
recruitment with the willingness of specialist 
doctors to refer back, drugs do not meet the 
FORNAS criteria, PIC PRB at the hospital does not 
know about PRB drugs and their restrictions, 
patients not being referred back by the specialist at 
the hospital, and there are no recommendation 
criteria to determine stable patients who can be 
referred back. 
There are two pharmaceutical services in one pharmacy 
room for certain days at the three districts' primary 
healthcare. As a consideration in Law Number 36 of 
2014 concerning health workers article 46 paragraphs 
1,2 and 5 and Permenkes RI, Number 74 of 2016 
concerning standards of pharmaceutical services in 
primary healthcare, article 7 and article 3 paragraph 1 
stated that the pharmacy staff of the PRB Pharmacy 
service that provides pharmaceutical services in the 
primary healthcare pharmacy must have SIPA 
(license).9,10 Also, PRB Pharmacist that provides PRB 
drug pharmaceutical services in the primary healthcare 
pharmacy room still has to carry out standard 
pharmaceutical services for PRB Pharmacy. 
Research by Paramita A et al. (2019) reported that the 
main problems of PRB implementation are: the limited 
availability of PRB drugs in primary healthcare, 
prolonged queue time because of patients accumulation 
in the hospital, notification of "potential PRB" status on 
patients in the VCLAIM program at the hospital tends 
to be ignored, low compliance of medical personnel in 
the hospital in completing the referral form feedback, 




Tabel 1. Recapitulation of Policy Implementation 
Performance related to the procurement of PRB 
drugs in the Subdistrict Primary Healthcare Center 
Pharmacy room and PRB Pharmacy in Central 
Jakarta Quarter I, II, and III of 2019 
No Indicators 
Not Yet Started 
Has Started but 
not yet optimal 
Has been 
optimal 




  √ √   
2 Human resources   √ √   
3 Funding   √ √   




    √ √ 
6 
Easy access  (e-
monev, e-catalog)   √   √  















































  √ √ 
17 Economic   √ √   
18 Politic     √ √ 
*PHC: Primary Healthcare Center, Phar: Pharmacy 
Policy standards and objectives 
There are still obstacles in policy implementation 
performance in the monitored indicators so that it is 
not optimal according to the target and the number of 
collaborators. 
Resources 
2 out of 8 subdistricts primary healthcare center have 
only one pharmacist. Human resources at PRB 
Pharmacy are sufficient. From the triangulation, we 
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primary healthcare center have not been implemented 
optimally, and many of the PRB Pharmacists are not on 
standby during service hours. In the Republic of 
Indonesia Minister of Health Regulation No.43 of 2019 
concerning primary healthcare center and workforce 
standards, to increase the number of services PRB 
drugs and maximize the standard of pharmaceutical 
services, more than one pharmacist is needed.
12 
 
The primary healthcare center drug budget was from 
the regional public service agencies. PRB pharmacies 
budget from private and state-owned funds. The drug 
planning process starts from preparing online planning 
through the e-monev system, procurement / e-
purchasing through the e-catalog system, or other 
programs according to the Presidential Regulation on 
Procurement of B/J by the Government. All PRB 
Pharmacies in Central Jakarta in the 1st, 2nd, and 3rd 
quarter of 2019 have not received an e-monev account. 
A policy or program will not be able to achieve its 
goals or objectives without adequate budget support.
13
  
The procurement of PRB drugs by the dispensary 
pharmacy needs to be adjusted to the Republic of 
Indonesia Minister of Health Regulation No. 9 of 2017 
concerning Pharmacy, article 17 paragraph 1 letter a 
and paragraph 2, which states "Pharmacy can only 
submit pharmaceutical preparations, medical supplies, 
and consumable medical materials to other pharmacies 
to meet the shortage in the number of preparations."
14
 
Hann (2007) stated that there are two alternative policy 
implementations: implementing them in the form of 
programs or making derivative policies.7 This is related 
to the need for a legal umbrella in providing PRB drugs 
in primary healthcare center. Research by Maryani H, 
Kristiana L, Andarwati P, Paramita A, and Aimanah IU 
(2019) stated that "another obstacle faced by primary 
healthcare center is that some drugs that are already 
included in the list of DRR drugs in the hospital are still 




PRB drugs often unavailable at PRB Pharmacies are 
Irbesartan 150 mg, Irbesartan 300 mg, Diovan, 
Sopralan, Miniaspi, Adalat Oros, ISDN, Diamicrone, 
and Phenytoin. This condition follows the Annex to 
Permenkes RI No.28 of 2014 concerning the JKN 
Program Implementation Program; chapter IV letter D 




Communication between Organizations 
Policy transmissions are delivered through meetings, 
WA groups, telegrams, and letters addressed to PRB 
Pharmacies and Primary healthcare centers. Not all of 
them understand the information provided regarding 
PRB. The transmission of understanding in forwarding 
policy messages is not optimal at the executive level. 
George C. Edwards stated that if we want to make 
policy implementation effective, then implementation 
orders must be consistent and clear. 
17  
The attitude of the implementers 
Initially, some primary healthcare centers refused to 
implement the program. Only pharmacies that can fund 
the programs accepted the policy implementation. 
Moreover, the Central Jakarta BPJS Kesehatan has not 
implemented a reward and punishment system. George 
C. Edwards argues that one of the techniques 
suggested high-level policymakers overcome the 
likelihood of implementers by manipulating incentives 
such as reward/punishment so that it is likely to 
influence policy implementers' actions.
17 
Characteristics of the Implementing Organization 
Fragmentation of the organizational structure 
subdistrict primary healthcare supports implementing 
PRB drugs procurement policies because of the 
accreditation. PRB pharmacies have not implemented 
optimally Permenkes No. 73 of 2016. Primary 
healthcare providers of PRB drugs already have their 
own SOPs, but not all PRB Pharmacies. SOPs 
uniformity is the officials' actions in complex and 
widespread organizations and has significant 
similarity in applying regulations. 
17 
The Economic, Social, and Political Environment 
The social environment inside and outside the Health 
Office, Primary healthcare, and PRB Pharmacy 
support the procurement and service of PRB drugs. 
Implementation in Subdistrict Primary Healthcare is 
supported by the Head of the Health Office and the 
Governor of DKI Jakarta Province. The leader of the 
Pharmacy also supports implementation at the 
Pharmacy. Because not all primary healthcare has the 
same amount of BLUD income, it requires a legal 
umbrella in PRB drug procurement management. 
There are still PRB participants who prefer to seek 
treatment and meet specialist doctors at the hospital. 
Hospitals have an essential role in the successful 





The implementation of policies related to the 
procurement of PRB drugs in the subdistrict primary 
healthcare pharmacy room and PRB Pharmacy in 
Central Jakarta for the first, second, and third quarter 
of 2019 have been carried out by 8 PRB pharmacies 
from 293 pharmacies and 2 out of 8 subdistricts 
primary healthcare as pilot projects with not optimal 
results. The following reasons are: 
1. Subdistrict primary healthcare: The attitude, 
response, and commitment of the implementers 
119 
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are influenced by the support of the economic 
environment, the availability of SOPs, the absence 
of a particular legal umbrella, and communication 
between organizations which includes clarity, 
method, consistency in delivery, objectives and 
policy objectives. Not all of the resources involved 
have a clear understanding of the standards and 
policy objectives. It is also affected by the 
fulfillment of resources, including the availability 
of human resources for pharmaceutical services in 
several sub-districts primary healthcare, the 
availability of funds/budgets that affect the PRB 
drug planning process, the time required for drug 
fulfillment, and the absence of incentives or 
rewards and punishments. 
2. PRB Pharmacy: The attitude, response, and 
commitment of the implementer are influenced by 
the support of the economic environment, the 
availability of SOPs, and the pharmacy's 
organizational structure as well as communication 
between organizations which includes clarity, 
method, consistency of delivery, policy objectives, 
and objectives, fulfillment of human resource 
discipline, availability of funds/budget, the PRB 
drug planning process, the time needed to fulfill 
the drugs, the absence of incentives or 
rewards/punishments, and the lack of easy access 
to orders through e-catalogs in the process of 




Ministry of Health of the Republic of Indonesia:  
1. Disseminate the policies issued so that 
implementers can understand, have the same 
perception, and do not have different 
interpretations to support health services 
optimization. 
2. Compile data collection of FORNAS drugs that 
are not available in e-catalog shows and find 
solutions to display all PRB drugs.  
3. Provide e-purchasing access through an e-catalog 
account to PRB Pharmacies and other health 
facilities that have sent RKOs on the e-monev 
application system. 
4. Create policies and a strict monitoring system so 
that e-purchasing access to the e-catalog can only 
be used for health facilities/pharmacies that have 
submitted RKOs through the e-monev application 
system. 
5. Create policies that regulate the granting of 
sanctions to the pharmaceutical industry and drug 
distributors who are in default. 
6. Create policies to coordinate with relevant 
collegium to provide PRB requirements for 
patients for the specialist doctor in 
FKTRL/hospital. 
BPJS Kesehatan 
Coordinate with the Health Office in formulating PRB 
policies in DKI Jakarta. 
 
BPJS Kesehatan Central Jakarta Branch:  
1. Disseminate BPJS Kesehatan policies 
appropriately to the management elements and 
field technical officer so that these policies can be 
understood and implemented correctly. 
2. Create a patient and PRB drugs information 
system for primary healthcare, PRB Pharmacy, 
and other health facilities to facilitate PRB drug 
planning and minimize the occurrence of drug 
planning errors. 
3. Create a system of guidance, monitoring, and 
evaluation at the primary healthcare facility, 
hospital, and PRB Pharmacy with a 
rewards/punishments system to increase 
commitment to PRB and shorten verification 
process time of drug claim files; thus, speed up 
the time for claim payments. 
DKI Jakarta Provincial Health Office:  
1. Create a derivative legal umbrella policy as a 
reference for the Subdistrict Primary Healthcare 
in planning, procurement, and PRB drugs service 
by paying attention to compliance with 
pharmaceutical service standards in primary 
healthcare. 
2. Disseminate and ensure implementers understand, 
have the same perception, and do not have 
different interpretations of each Health Office 
policy. 
3. Periodically monitor and evaluate the 
implementation of policies to achieve policy 
objectives and targets.  
4. Evaluate and control constraints in the field with 
the relevant sectors. 
 
Central Jakarta Health Office 
Increase development, supervision, and control 
activities to the primary healthcare, pharmacies, and 
other health facilities. 
 
LKPP:  
1. Improve coordination with the Ministry of Health 
and BPOM in monitoring and evaluating the 
process of government procurement of 
goods/services as a basis for formulating policies.  
2. Implement rewards and punishments to the 
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Next Researcher:  
Include elements from the Ministry of Health and 
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